Searched for
INTAS PHARMACEUTICALS IPO
Sudeep Pharma IPO to open tomorrow; GMP rises 22%. Should you apply?Sudeep Pharma IPO: Shares are seeing solid momentum in the grey market, trading at a 21.92% premium to the issue price of ₹593. At this GMP...- Sudeep Pharma IPO: GMP jumps 16% ahead of November 21 launch. Check tentative listing priceSudeep Pharma’s Rs 895-crore IPO is set to open on November 21, comprising a Rs 95-crore fresh issue and an Rs 800-crore OFS. The price ban...
- Sudeep Pharma sets IPO price band at Rs 563-593; issue to open on November 21Sudeep Pharma has set a price band of Rs 563–593 for its Rs 895 crore IPO, which opens on November 21. The issue comprises a fresh issue an...
- Sudeep Pharma files draft papers with Sebi to mop up funds via IPOVadodara-based Sudeep Pharma has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial public offe...
- Temasek in advanced talks for 40% stake in True North-owned IntegraceTemasek will invest about Rs 550 crore ($75 million) in Integrace at a valuation of about Rs1200 crore, people aware of the development tol...
- ChrysCapital to sell 10% in drug maker Intas Pharmaceuticals to Temasek for over $160 millionTemasek has bought 12.5% stake in Intas Pharmaceuticals, one of India's top 10 drug makers by sale, for a little over Rs 1,100 crore, peopl...
- Temasek, two other PEs eye ChrysCapital’s 10 pc stake in Intas PharmaThree private equity funds are in independent talks to purchase rival ChrysCap’s stake Intas Pharmaceuticals for about $150 million or Rs 9...
- IPO: Sebi gives green signal to offerings of Advanced Enzyme Tech, Intas PharmaMarket regulator Sebi has given nod to the proposed initial public offerings of two companies-- Advanced Enzyme Technologies and Intas Phar...
- Intas settles patent litigation with Hoffmann-La Roche for capecitabine tabletAhmedabad-based drug maker, Intas Pharmaceuticals Ltd and its US-based wholly owned subsidiary Accord Healthcare Inc. has entered into a se...
- Intas ex-employee objects to amalgamation planAn affidavit of objection challenging Intas' amalgamation was filed by Mani Iyer, a former executive director of Intas Biopharmaceuticals, ...
- Volatile market takes toll on Pharmaceuticals and healthcare IPO plansThe market has hit the IPO plans of pharma and healthcare companies with several firms either withdrawing or deferring their offers.
- ChrysCap to buy Rs 300-cr stake in Intas PharmaceuticalsPrivate equity firm ChrysCapital is buying an additional stake in Intas Pharmaceuticals for Rs 300 crore after the Ahmedabad-based drug mak...
- ChrysCapital set to raise stake in Intas Pharmaceuticals ahead of deferred IPOAlthough the stake could not be be confirmed, the pre-IPO deal will increase ChrysCapital's holding in the company to over 15% from 11.3% c...
- ChrysCapital, Blackstone and Advent Capital in race to buy stake in Intas Pharma for Rs 250 crore3 PE firms are vying for a minority stake in generic drugmaker Intas Pharmaceuticals, two people familiar with the development told ET.
- Intas gets SEBI nod for IPO for raising Rs 800 croreIntas Pharmaceuticals has received SEBI clearance for its IPO. The issue was expected to hit the market in May, but Intas is still undecide...
- Intas Pharma files documents with Sebi for IPODrug maker Intas Pharmaceuticals today said it has filed documents with market regulator Sebi for an initial public offer that includes sal...
- Apax, KKR in talks to acquire Blackstone stake in EmcureHealthcare is 1 of the 5 sectors in which Apax Partners invests globally, besides technology & telecom, retail & consumer, media, financial...
- Intas Biopharma in talks with Japanese co for outlicensingIntas Biopharmaceutical Ltd, a group company of the Rs 1,600-crore Intas Pharmaceuticals Ltd, would soon enter into an out-licensing and su...
- Many deals didn’t meet our investment criteria: Chrys CapitalIn conversation with ET , Mr Kaul, managing director, ChrysCapital discusses the changing landscape of Indian pharma and the firm’s investm...
- Intas Pharma IPO to raise Rs 800 cr, fund acquisitionsIntas Pharma plans to raise Rs 750-800 cr through IPO that will help it raise fresh funds for acquisitions besides allowing PE investor Chr...
Load More
